EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

Size: px
Start display at page:

Download "EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb"

Transcription

1 EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb A. Medina Servicio de Cardiología Hospital Universitario de Gran Canaria Dr. Negrín Islas Canarias (Spain)

2 Provisional stenting has been proved to be the treatment of choice in most bifurcated coronary lesions. BVS: concern about the scaffold integrity with balloon intervention (balloon diameter mm). Our own in vitro test shows integrity of BVS (1 or 2 balloon and low pressure inflation).

3 Provisional BVS implantation Lesion located in a major bifurcation point MB 2.5 mm in diameter SB 2.25 mm in diameter SB lesion length < 10 mm 99 bifurcated coronary lesions SBA + B0 B0 B1 B2 B3 n = 12 n = 41 n = 10 n = 29 n = 1 Kissing Balloon 26 DES in the SB Two stent (elective inverted T) SMS 3 n = 6

4 B2 BVS + KB KISSING BALLOON (8 atm) 3.5 x 28 mm BVS (16 atm) FGBody temperature Facilitates SB access? 1 2 S I D E 2.5 x 15 mm (8 atm) M A I N B R A N C H F I R S T n = 8 BVS 3.5 mm (3 & 2.5 mm) Mild waist in second balloon V E S S E L F I R S T Optimal geometry of MV scaffolding 3.5 x 28 mm BVS after KB (3-2.5) 3 x 25 mm (8 atm) Mild waist in second balloon n = 5 BVS 3 mm (2.5 & 2.5 mm)

5 A paradox : Kissing balloon Larger maximum diameter and less crown stretching 3.5 mm BVS overexpanded Eccentric Concentric crown link ondulated non ondulated Kissing Oversizing 3 mm 5.5 mm 4.5 mm 4.5 mm BVS integrity 2.5 mm BVS fracture Area mm 2 Area mm 2

6 Predilation (direct BVS failed) #39# {1,1,1} 3.5 x 18 mm BVS SB 1 st MV 1 st 1 2 MV 2 nd SB 2 nd LAD 3 mm Dg 2.5 mm (8 atm) After KB inflation

7 BASELINE Dg Measurements taken before SB origin LAD MLA 3.42 mm 2 AFTER BVS BVS 3.5 mm 14 atm Dg LAD CORONARY VESSEL WALL CONTROLS EXPANSION OF BVS BVS 3.5 mm 14 atm CSA 8.75 mm 2 KB 3 & 2.5 mm 8 atm Dg CSA 9.64 mm mm 2 Area < recommended limit wire LAD KB 3 & 2.5 mm 8 atm 3.5 mm BVS: 100% expansion = 9.6 mm 2 4 mm balloon = mm 2 AFTER BVS

8 BVS & Kissing A) Balloons selection: - MB balloon 0.5 mm less than BVS diameter - SB balloon 2.5 mm BVS diameter MB balloon SB balloon 3.5 mm 3 mm 2.5 mm 3 mm 2.5 mm 2.5 mm B) Balloons inflation pressure 8 atm

9 Clinical data n=26 Age, years 59 ± 12 Male gender 22 (85) Hypertension 12 (48) Diabetes mellitus 6 (23) Hypercholesterolemia 12 (48) Current smoking 15 (60) Unstable 22 (85) Multivessel disease 8 (30) Baseline angiographic data n=26 Location of the lesion, n (%) LAD-Dg LCx-Cx RCA Type of lesion, n (%) {1,1,1} {1,1,0} {1,0,1} {0,1,1} {1,0,0} {0,1,0} {0,0,1} 17 (65) 6 (23) 3 (12) 11 (42) 6 (23) 0 (0) 5 (19) 2 (8) 2 (8) 0 (0) QCA Main vessel Side branch Lesion length, mm 21.9 ± ± 2.1 {_,_,1} 16 (61%) Left ventricular EF 63 ± 13 Data are expresed as n (%) Prox. reference diameter 2.97 ± 0.37 Distal reference diameter 2.53 ± ± 0.3 MLD, mm 1.13 ± ± 0.41 DS,% 62 ± ± 16 *BVS diameter was selected according to proximal vessel diameter

10 Baseline QCU (n =26) Baseline Dg Proximal Before SB origin After SB origin Distal MLA LAD 8,74 mm 2 2,14 mm 2 2,47 mm 2 3,96 mm 2 Main branch SB Proximal Before SB origin MLA After SB origin Distal Ostium EEL, mm ± ± ± ± ± ± 2.8 Mean diameter,mm 3.20 ± ± Lumen area, mm ± ± ± ± ± ± 1.8 Plaque area, mm ± ± ± ± ± ± 1.1 Plaque burden, % 44 ± ± ± ± ± ± 15 MLA location, n 4 (16%) 3 (12%) (46%) 2 (8%) 5 (25%) Eccentric (MLA), n (40%) *BVS diameter was selected according to proximal main branch diameter

11 After BVS implantation Area 4.67 mm2 MeanD 2.43 mm Min 2.20 Max 2.68 Area 5.23 mm2 MeanD 2.57 mm Min 2.39 Max 2.93 After SB origin Before SB origin LAD D Dg P After Kissing Δ 1.29 mm 2 Area 4.55 mm2 MeanD 2.40 mm Min 2.15 Max 2.63 Area 6.52 mm2 MeanD 2.87 mm Min 2.60 Max 3.18 LAD D Dg P

12 Procedural data BVS 2.5 mm n= 4 BVS 3 mm n= 9 BVS 3.5 mm n= 13 KB n = 26 KB n = 26 IVUS guidance, n 26 (100%) Direct BVS implantation, n 16 (62%) MB predilation after failure, n 6 (23%) Elective MB predilation, n 4 (15%) MB balloon diameter, mm 2.44 ± 0.16 MB balloon length, mm 17.7 ± 2.6 MB balloon pressure, atm 8.4 ± 2 BVS diameter, mm 3.16 ± 0.37 BVS length, mm 24 ± 8 BVS inflation pressure, atm 15.9 ± 1.9 BVS inflation time, s 72 ± 16 KISSING BALLOON DATA MB balloon diameter, mm 2.76 ± 0.30 MB balloon length, mm 16.6 ± 2.9 MB balloon pressure, atm 7.6 ± 0.9 SB balloon diameter, mm 2.39 ± 0.25 SB balloon length, mm 16 ± 3 SB balloon pressure, atm 7.7 ± 1.2

13 Changes in BVS geometry after kissing balloon Dg LAD LAD Before KB After KB p PROXIMAL BVS SEGMENT Area, mm ± ± BEFORE SB ORIGIN Area, mm 2 SI 6.70 ± ± ns AFTER SB ORIGIN Area, mm ± 1.76 SI ± ns DISTAL BVS SEGMENT Area, mm ± ± SI (BVS symmetry index) Nominal BVS expansion Maximum tolerated expansion 3 mm Ø = 7.1 mm 2 (3.5 mm Ø = 9.6 mm 2 ) 3.5 mm Ø = 9.6 mm 2 (4 mm Ø = mm 2 )

14 Major adverse cardiac events and follow-up results (KB) Primary success (one patient needed SB stenting) 100% IN HOSPITAL KB n=26 Non-Q-wave MI 1 (4%)* Death 0 Sub-acute BVS thrombosis (PAMI) 1 (4%) FOLLOW-UP (7 ± 3 months) Recurrent infarction 0 Death (all causes) 0 Need of TLR 0 BVS thrombosis 0 Total MACE 2 (8%) * troponin elevation within 48 h post-procedure of 5 ULN with either symptoms of myocardial ischemia, new ischemic ECG changes, or documented complications during the procedure Angio-CT was performed at follow-up (n = 25). No restenosis

15 T stenting after kissing: BVS (MB) & DES (SB) #97# {0,1,1} DES BVS 3 x 18 mm BVS KB inflation 2.25 x 18 mm DES

16 Conclusions Kissing balloon for bifurcated coronary lesions treated with BVS seems to be safe and feasible Kissing balloons inflation ( 8 atm) Kissing balloons selection - MB 0.5 mm less than BVS diameter - SB 2.5 mm Mid-term clinical & angio CT follow up encouraging. IVUS or OCT guidance should be used more frequently than with metallic stent. 2-3 YEARS FOLLOW-UP WILL PROVIDE A MORE DEFINITIVE ANSWER

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

Bifurcation stenting with BVS

Bifurcation stenting with BVS Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have

More information

FFR-guided Jailed Side Branch Intervention

FFR-guided Jailed Side Branch Intervention FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still

More information

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy STENTYS for Le, Main Sten2ng Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement or affilia2on

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

Insight from the CACTUS trial Coronary Bifurcation Application of the Crush

Insight from the CACTUS trial Coronary Bifurcation Application of the Crush EBC - Prague 26-28 september 2008 Insight from the CACTUS trial The role of final kissing balloon inflation F. Airoldi,, A. Colombo San Raffaele Scientific Institute EMO Centro Cuore,, Columbus Hospital

More information

Side Branch Occlusion

Side Branch Occlusion Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion

More information

September Peter Barlis. Royal Brompton Hospital, London, UK

September Peter Barlis. Royal Brompton Hospital, London, UK 3rd EBC Meeting European Bifurcation Club September 2007 PALAU DE LA MUSICA, SalaRodrigo VALENCIA, SPAIN Culotte Technique in Left Main Disease Peter Barlis Carlo DiMario Royal Brompton Hospital, London,

More information

Why I try to avoid side branch dilatation

Why I try to avoid side branch dilatation Why I try to avoid side branch dilatation Hyeon-Cheol Gwon Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Why I don t kiss? I kiss! I prefer to discuss SB ballooning rather

More information

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ DR ΝΙΚΟΛΑΟΣ ΚΑΥΚΑΣ MD, FESC Διευθυντής, Υπεύθυνος Αιμοδ/κού Εργαστηρίου Καρδιολογική Κλινική Γεν. Νοσοκομείο ΚΑΤ-ΕΚΑ PCI in Coronary Bifurcations Bifurcations

More information

PCI for Long Coronary Lesion

PCI for Long Coronary Lesion PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2

More information

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD. Left Main and Bifurcation Summit IVUS-Guided d Provisional i Stenting: ti Plaque or Carina Shift Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan College of Medicine Asan Medical Center,

More information

Percutaneous Intervention of Unprotected Left Main Disease

Percutaneous Intervention of Unprotected Left Main Disease Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected

More information

Protection of side branch is essential in treating bifurcation lesions: overview

Protection of side branch is essential in treating bifurcation lesions: overview Angioplasty Summit TCT Asia Pacific Seoul, April 26-28, 2006 Protection of side branch is essential in treating bifurcation lesions: overview Alfredo R Galassi, MD, FACC, FSCAI, FESC Head of the Catetherization

More information

Final Kissing Ballooning Returns? The analysis of COBIS II registry

Final Kissing Ballooning Returns? The analysis of COBIS II registry Final Kissing Ballooning Returns? The analysis of COBIS II registry Hyeon- Cheol Gwon Heart Vascular & Stroke Ins?tute, Samsung Medical Center Sungkyunkwan University School of Medicine Final Kissing Ballooning

More information

Contemporary therapy of bifurcation lesions

Contemporary therapy of bifurcation lesions Contemporary therapy of bifurcation lesions Dr Angela Hoye MB ChB PhD MRCP Interventional Cardiologist Kingston-upon-Hull, UK Hull The challenge of bifurcations Risk of peri-procedural infarction Relatively

More information

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Le# main treatment with Stentys stent Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement

More information

Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot'

Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot' OCT guided BVS for LMCA to LAD : Optimising the 'Pot' Dr Aniket Puri MD,DM,FRACP, FACC, FSCAI, FAPSIC Consultant Interventional Cardiologist Christchurch Hospital and Canterbury DHB(Univ of Otago) Christchurch,New

More information

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. In-stent restenosis (ISR) Remains important issue even in the

More information

Post PCI functional testing and imaging: case based lessons from FFR React

Post PCI functional testing and imaging: case based lessons from FFR React Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest

More information

DESolve NX Trial Clinical and Imaging Results

DESolve NX Trial Clinical and Imaging Results DESolve NX Trial Clinical and Imaging Results Alexandre Abizaid, MD, PhD, Instituto Dante Pazzanese, Sao Paulo, Brazil On behalf of the DESolve Nx Trial Investigators Please refer to the TCT2014 App or

More information

A Paclitaxel-Eluting Balloon for Bifurcation Lesions : Early Clinical Observations

A Paclitaxel-Eluting Balloon for Bifurcation Lesions : Early Clinical Observations Innovative Devices : Non Stent Technologies : Drug Eluting Balloons A Paclitaxel-Eluting Balloon for Bifurcation Lesions : Early Clinical Observations Pieter R. Stella, MD Director CardioVascular Research

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

Non-LM bifurcation studies of importance in 2011

Non-LM bifurcation studies of importance in 2011 7th European Bifurcation Club 14-15 October 2011 LISBON Goran Stankovic MD, PhD Non-LM bifurcation studies of importance in 2011 October 15 th : 08:00 08:10 DKCRUSH-II: A Prospective Randomized Trial of

More information

6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France

6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France 6 th European Bifurcation Club 22-23 October 2010 - BUDAPEST Kissing in simple strategy? Why and how I kiss Y. Louvard, ICPS, Massy France A long experience of kissing 1996 Patients 79 Final Kissing balloon

More information

I have nothing to disclose.

I have nothing to disclose. I have nothing to disclose. ESC congress of cardiology, 25-29th August 2012, Munich, Germany Minsk-Village 6, August 26 th, 2:22 PM Session: The grey zone of coronary interventions: The real bifurcation

More information

Welcome to the 8 th European Bifurcation Club October Barcelona

Welcome to the 8 th European Bifurcation Club October Barcelona Welcome to the 8 th European Bifurcation Club 12-13 October 2012 - Barcelona Safety and clinical efficacy of Sideguard stent for treatment of bifurcation lesions Interim results from European multicentre

More information

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Onassis Cardiac Surgery Center, Athens, Greece Critical issues in LM PCI Anatomic variability Techniques Variability

More information

Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI

Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent Masahiko Ochiai MD, FACC, FESC, FSCAI Division of Cardiology and Cardiovascular Surgery Showa University Northern Yokohama Hospital

More information

Bifurcation Stenting: IVUS and OCT Information

Bifurcation Stenting: IVUS and OCT Information Bifurcation Stenting: IVUS and OCT Information Yoshinobu Murasato MD, PhD (New Yukuhashi Hospital) On behalf of J-REVERSE investigators October 14-15, 2011, Lisbon Proximal stent deformation induced by

More information

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) & Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) & Biomatrix TM Single Center Experience (Indonesia)(Final 5 Yr F up) T. Santoso University of

More information

Between Coronary Angiography and Fractional Flow Reserve

Between Coronary Angiography and Fractional Flow Reserve Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional

More information

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ".

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique . Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ". "Σύμπλοκη αγγειοπλαστική βλάβης διχασμού LAD/Diagonal (Medina 1,1,1) με την τεχνική DK crush ". Anastasios

More information

Bernard Chevalier Institut Jacques Cartier, Massy, France. Patrick W. Serruys Imperial College, London, UK Erasmus University MC, Netherlands

Bernard Chevalier Institut Jacques Cartier, Massy, France. Patrick W. Serruys Imperial College, London, UK Erasmus University MC, Netherlands The 4-year Clinical Outcomes of the ABSORB II Trial: First Randomized Comparison between the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold and the Everolimus Eluting Stent Bernard Chevalier

More information

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections Martin B. Leon, MD Columbia University Medical Center Cardiovascular Research Foundation New York City Angioplasty

More information

Plaque Shift vs. Carina Shift Prevalence and Implication

Plaque Shift vs. Carina Shift Prevalence and Implication TCTAP 2013 Fellowship Course Left Main and Bifurcation PCI: Bifurcation PCI Plaque Shift vs. Carina Shift Prevalence and Implication Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan

More information

Mid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators

Mid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators Mid-term results from real-world REPARA registry Felipe Hernandez, on behalf of the REPARA investigators Potential conflicts of interest Speaker's name: Felipe Hernandez I have the following potential

More information

Integrated Use of IVUS and FFR for LM Stenting

Integrated Use of IVUS and FFR for LM Stenting Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT01724957 Dobrin Vassilev MD, PhD Assoc. Prof. in Cardiology Head Cardiology Clinic, Alexandrovska University Hospital Medical

More information

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Prof. Ran Kornowski, MD, FESC, FACC Director - Division of Interventional Cardiology Rabin Medical Center and Tel Aviv University,

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection

Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection Carlo Trani, MD, FESC Cardiology Department, Catholic University of the Sacred Heart, Rome - Italy How would you treat

More information

Flexibility of the COMBO Dual Therapy Stent

Flexibility of the COMBO Dual Therapy Stent TM CaseSpotlight Flexibility of the COMBO Dual Therapy Stent Doctor Peter den Heijer is an of the Catheterization Laboratory at the Department of Cardiology of the Amphia Ziekenhuis, Breda, The Netherlands.

More information

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

The Tryton Side Branch System in Distal Left Main PCI

The Tryton Side Branch System in Distal Left Main PCI The Tryton Side Branch System in Distal Left Main PCI Yaron Almagor, MD Director, Interventional Cardiology Shaare Zedek Medical Center Jerusalem, Israel TCTAP Seoul April 2013 Speaker s name: YARON ALMAGOR

More information

Declaration of conflict of interest. Nothing to disclose

Declaration of conflict of interest. Nothing to disclose Declaration of conflict of interest Nothing to disclose Hong-Seok Lim, Seung-Jea Tahk, Hyoung-Mo Yang, Jin-Woo Kim, Kyoung- Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Joon-Han

More information

Side branch occlusion in 500 ABSORB BVS

Side branch occlusion in 500 ABSORB BVS Side branch occlusion in 500 ABSORB BVS Clinical implications and Solutions Robert-Jan van Geuns, MD, PhD Associate Professor,Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands On behalf

More information

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD Clinical Value of OCT Guidance for Coronary Stenting Giulio Guagliumi, MD 100 % Endovascular Imaging Indications of use 87.5 % 75 % 57.5 % 50 % 45 % 25 % 15 % 0 Lesion morphology Stent optimization Lesion

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

Drug Eluting Stents: Bifurcation and Left Main Approach

Drug Eluting Stents: Bifurcation and Left Main Approach TCT Asia 2006 Drug Eluting Stents: Bifurcation and Left Main Approach Eberhard Grube MD FACC, FSCAI Heart Center,, Germany Stanford University, School of Medicine, CA, USA DES in High Risk Lesions TAXUS

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

OCTOBER. OCT Optimised Bifurcation Event Reduction. A Nordic Baltic British clinical outcome trial

OCTOBER. OCT Optimised Bifurcation Event Reduction. A Nordic Baltic British clinical outcome trial OCT Optimised Bifurcation Event Reduction A Nordic Baltic British clinical outcome trial NIELS RAMSING HOLM, Skejby Denmark Study start: OCTOBER 2016 OCTOBER LMCA or non-lmca bifurcations with SB 2.5mm

More information

Y. Louvard, ICPS, Massy, France. TCT Asia Pacific 2010

Y. Louvard, ICPS, Massy, France. TCT Asia Pacific 2010 Provisional Bifurcation Stenting: Main Branch First Y. Louvard, ICPS, Massy, France TCT Asia Pacific 2010 No conflict of interest to declare M Main prox. first A Main Accross side first D Distal first

More information

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica Kyanous Stavros, Thessaloniki.

More information

What Coronary Specialists Teach The Vascular Community About Vessel Prep? Tony Das, MD Texas Health, Dallas Dallas, Texas

What Coronary Specialists Teach The Vascular Community About Vessel Prep? Tony Das, MD Texas Health, Dallas Dallas, Texas What Coronary Specialists Teach The Vascular Community About Vessel Prep? Tony Das, MD Texas Health, Dallas Dallas, Texas Stent Era Lessons on Vessel Preparation Under expanded stent consequences Abrupt

More information

PCI for In-Stent Restenosis. CardioVascular Research Foundation

PCI for In-Stent Restenosis. CardioVascular Research Foundation PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse

More information

POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) - Interim analysis

POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) - Interim analysis POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) - Interim analysis Robert J. Gil 1,2, MD, PhD, FESC 1- Mossakowski Medical Research Centre, Polish Academy of Sciences 2- Invasive

More information

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC Seoul, Korea: 25-27 27 April 2007 Session: Left mains & bifurcation intervention An integrated approach to bifurcation lesions: lessons from years of randomized

More information

Patrick W. Serruys Imperial College, London, UK Erasmus University MC, Rotterdam, the Netherlands

Patrick W. Serruys Imperial College, London, UK Erasmus University MC, Rotterdam, the Netherlands TCT 2014 13 Sep 2014-17 Sep 2014, Washington, DC - U.S.A Plenary Session XII : Late-Breaking clinical Trials #2 ABSORB II : A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold

More information

FFR and IVUS Guided DES Implantation in Long Diffuse Lesions

FFR and IVUS Guided DES Implantation in Long Diffuse Lesions FFR and IVUS Guided DES Implantation in Long Diffuse Lesions Can We Reach Optimal DES Expansion With Conventional Stent Delivery System in Long Diffuse Lesion? Seung-Jea Tahk, MD., PhD. Ajou University

More information

eluting Stents The SPIRIT Trials

eluting Stents The SPIRIT Trials Everolimus-eluting eluting Stents The SPIRIT Trials Gregg W. Stone, MD Columbia University Medical Center Cardiovascular Research Foundation Abbott XIENCE V Everolimus-eluting eluting Stent Everolimus

More information

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao) The Microport FIREBIRD Polymer-based Sirolimus- Eluting Stent Clinical Trial Program Update: The FIC and FIREMAN Registries Junbo Ge, MD, FACC, FESC, FSCAI On behalf of Runlin Gao (FIC PI) and Haichang

More information

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G.

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Ellis MD Dean J. Kereiakes MD and Gregg W. Stone MD for the ABSORB

More information

Consensus so far and what we will be focusiong on this time

Consensus so far and what we will be focusiong on this time Consensus so far and what we will be focusiong on this time The 6 th European Bifurcation Club Meeting Budapest October 22-23 2010 Jens Flensted Lassen, MD, PH.D., FESC. Department of Cardiology B Skejby

More information

Biodegradable Stents An update and work-in

Biodegradable Stents An update and work-in Biodegradable Stents An update and work-in in-progress Department of Cardiology, Hideo Tamai, M.D. Metallic stents... Background induce a varing degree of thrombogenesis eg, subacute thrombosis in complex

More information

Update from the Tryton IDE study

Update from the Tryton IDE study Update from the Tryton IDE study Maciej Lesiak EBC 2015 - Athens The Tryton Bifurcation Trial: A randomized comparison of a provisional one-stent vs. a dedicated two-stent strategy for true bifurcation

More information

Dr. Robert J. van Geuns. Thoraxcenter ErasmusMC Rotterdam On behalf of Dr. Jean Fajadet and Co-investigators

Dr. Robert J. van Geuns. Thoraxcenter ErasmusMC Rotterdam On behalf of Dr. Jean Fajadet and Co-investigators Complex coronary bifurcation lesions treated with the novel polymer-free dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and angiographic results of the prospective, multicenter bipax

More information

Drug eluting balloons in CAD

Drug eluting balloons in CAD Drug eluting balloons in CAD Ioannis Iakovou, MD, PhD Interventional Cardiology 1 st Cath Lab Onassis Cardiac Surgery Center Drug-Eluting Balloons (DEB) Technology and Applications 1. Special Features

More information

Lessons for technique and stent choice

Lessons for technique and stent choice 8 th European Bifurcation Club 12-13 October 2012 - Barcelona Session: What are the requirements for using a stent in a bifurcation? Lessons for technique and stent choice October 12 th : 16:45 17:50 Goran

More information

The 3 top Messages from technique Specific problems Solving

The 3 top Messages from technique Specific problems Solving The 3 top Messages from technique Specific problems Solving Alaide Chieffo Interventional Cardiology Unit San Raffaele Hospital Milan - Italy PROBLEMS DURING PROVISIONAL: SB PROTECTION AND RESCUE Francesco

More information

A Polymer-Free Dual Drug-Eluting Stent in Patients with Coronary Artery Disease: Randomized Trial Versus Polymer-Based DES.

A Polymer-Free Dual Drug-Eluting Stent in Patients with Coronary Artery Disease: Randomized Trial Versus Polymer-Based DES. A Polymer-Free Dual Drug-Eluting Stent in Patients with Coronary Artery Disease: Randomized Trial Versus Polymer-Based DES ISAR-TEST 2 Trial Robert A. Byrne, MB MRCPI Deutsches Herzzentrum and 1. Med.

More information

Current DES designs and expansion capacity testing

Current DES designs and expansion capacity testing construction of Sagrada Família basilica had commenced in 1882 anticipated completion date: 2026 Current DES designs and expansion capacity testing N. FOIN, MSc, PhD INTERNATIONAL CENTRE FOR CIRCULATORY

More information

Basics of Angiographic Interpretation Analysis of Angiography

Basics of Angiographic Interpretation Analysis of Angiography Basics of Angiographic Interpretation Analysis of Angiography Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Seoul, Korea What made us nervous Supervisors Stent Contrast

More information

Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece

Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece Bifurcation Stenting. European Bifurcation Club update. Ioannis Iakovou, MD Onassis Cardiac Surgery Center Athens, Greece The not so new development One vs. two stents General consensus In most bifurcational

More information

EBC Rules of Bifurcation PCI

EBC Rules of Bifurcation PCI EBC Rules of Bifurcation PCI Y. Louvard, ICPS, Massy, France What is a coronary bifurcation? «Murray s law» Bifurcation branching laws D1 Murray s law D 3* 3* 3* 1 = D 2 + D 3 D3 Finet s law D 1 = 0.67(D

More information

FFR Fundamentals and Measurements

FFR Fundamentals and Measurements FFR Fundamentals and Measurements Ghassan S. Kassab Thomas Linnemeier Chair Professor Biomedical Engineering, Indiana University Purdue University Indianapolis Principle of FFR Q S ( P P ) / R P max d

More information

REFCTRI/2010/ CTRI Website URL -

REFCTRI/2010/ CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Mon, 23 Apr 2018 20:30:46 GMT) CTRI Number CTRI/2010/091/000460 [Registered on: 15/10/2010] - Last Modified On 17/04/2012 Post Graduate Thesis Type of Trial

More information

Insight from Nordic III

Insight from Nordic III Insight from Nordic III Fifth European Bifurcation Club Meeting Berlin 16-17 October 2009 Jens Flensted Lassen, MD, PH.D., FESC. Department of Cardiology Skejby Hospital, University of Aarhus Denmark Nordic-Baltic

More information

DISAPPEARING STENT: IS THE TIME APPEARED?

DISAPPEARING STENT: IS THE TIME APPEARED? DISAPPEARING STENT: IS THE TIME APPEARED? Carlo Cernetti Chief Cardiology Division San Giacomo Hospital Castelfranco Veneto (TV) 1 THE BEGINNING START randomized study (n=452) Long-term follow-up The benefit

More information

ReZolve2 Bioresorbable Coronary Scaffold Clinical Program Update

ReZolve2 Bioresorbable Coronary Scaffold Clinical Program Update ReZolve2 Bioresorbable Coronary Scaffold Clinical Program Update Dr. David Muller St Vincent s Hospital Sydney, Australia 0 Potential conflicts of interest Speaker's name: Dr. David Muller I do not have

More information

Complex Coronary Interventions: Bifurcations. John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri

Complex Coronary Interventions: Bifurcations. John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri Complex Coronary Interventions: Bifurcations John M. Lasala MD PhD Professor of Medicine Washington University St Louis, Missouri Disclosures Advisory Board Boston Scientific, St. Jude Medical Speaker-

More information

Lessons learned From The National PCI Registry

Lessons learned From The National PCI Registry Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients

More information

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi PCI for Bifurcations: Which is the best strategy DK Crush,Culotte,SKS,T or TAP Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi CSI 2018 Selection

More information

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease

More information

PCI for Ostial Lesion

PCI for Ostial Lesion PCI for Ostial Lesion ii) LAD ostial Osamu Katoh,M.D. kyoto Katsura Hospital Cardiovascular Center PCI for a LAD ostial lesion is well-known to be associated with a high restenosis rate because of excessive

More information

Bifurcations Bad Krozingen I

Bifurcations Bad Krozingen I Bifurcations Bad Krozingen I Clinical outcome 5 years after routine T-Stenting versus provisional T-stenting in the treatment of de novo coronary bifurcation lesions using sirolimus-eluting stents M. Ferenc

More information

The Nordic Bifurcation Stent Technique Study. A Randomized trial of CRUSH vs CULOTTE Stenting

The Nordic Bifurcation Stent Technique Study. A Randomized trial of CRUSH vs CULOTTE Stenting The Nordic Bifurcation Stent Technique Study A Randomized trial of CRUSH vs CULOTTE Stenting Pål Gunnes, Matti Niemela, Kari Kervinen, Andrejs Erglis, Indulis Kumsars, Jens F Lassen, Michael Mæng, Jan

More information

Anatomical, physiological and clinical relevance of a side branch

Anatomical, physiological and clinical relevance of a side branch Anatomical, physiological and clinical relevance of a side branch : Which branch really needs a stent? Bon-Kwon Koo, MD, PhD, Seoul, Korea Bifurcation lesion: The GREAT EQUALIZER! No intervention = Balloon

More information

Intervention: How and to which extent is technology helping us?

Intervention: How and to which extent is technology helping us? Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction

More information

Bioabsorbable Scaffolding: Technology and Clinical Update. PD Dr. Nicolas Diehm, MD, FESC Inselspital, University Hospital Bern, Switzerland

Bioabsorbable Scaffolding: Technology and Clinical Update. PD Dr. Nicolas Diehm, MD, FESC Inselspital, University Hospital Bern, Switzerland Bioabsorbable Scaffolding: Technology and Clinical Update PD Dr. Nicolas Diehm, MD, FESC Inselspital, University Hospital Bern, Switzerland Disclosures I am not Ron Waksman 1 Clinical experience with AMS

More information

New Double Stent Technique

New Double Stent Technique New Double Stent Technique Jasvindar Singh MD, FACC Associate Professor of Medicine Barnes-Jewish Hospital/Washington University in St. Louis jzsingh@dom.wustl.edu New Double Stent Technique Jasvindar

More information

Journal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.

Journal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30. Journal of the American College of Cardiology Vol. 46, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.06.009

More information

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria I would like to express my personal gratitude to Dr. BK Koo for opening

More information

IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation

IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation SURE Trial: Restenosis in non-stented lesions Average of the two image slices with the smallest

More information

IVUS vs FFR Debate: IVUS-Guided PCI

IVUS vs FFR Debate: IVUS-Guided PCI IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement

More information

Insights from the Magmaris Clinical Data: BIOSOLVE II and BIOSOLVE III 12 Month Follow Up

Insights from the Magmaris Clinical Data: BIOSOLVE II and BIOSOLVE III 12 Month Follow Up Insights from the Magmaris Clinical Data: BIOSOLVE II and BIOSOLVE III 12 Month Follow Up Ron Waksman, MD FACC FSCAI FESC Professor of Medicine, Georgetown University Director, Cardiovascular Research

More information

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / / Patient Patient code Birth date: / / Sex: Male Height (cm): Female Weight (kg): Risk Factors: Family history of coronary disease: Hypertension Dyslipidemia Peripheral disease Diabetes Comorbidities: No

More information